Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
RTOG 0618
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
- NCT00551369 ↗
- Completed
- Radiation Therapy Oncology Group
- Standard
We haven't built an HCP commentary report on RTOG 0618 (operable stage I/II non-small cell lung cancer; tests no drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on RTOG 0618 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 12 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients With Operable Stage I/II Non-Small Cell Lung Cancer
- Phase
- Phase 2
- Status
- Completed
- Conditions
- Lung Cancer
- Interventions
- SBRT
- Arms
- SBRT · Experimental
- Enrollment
- 33
- Primary outcomes
- Primary Tumor Control at 2 Years
- Sponsor
- Radiation Therapy Oncology Group with National Cancer Institute (NCI), NRG Oncology
- Start
- Dec 2007
- Primary completion
- May 2012
- Results posted
- Yes
- Registry record
- NCT00551369 · updated Apr 30, 2019
Publications
linked from the registry- Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251. PubMed 29852037